Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,950 | -9,242 | -10,446 | -6,051 | -1,745 |
| Depreciation Amortization | 720 | 116 | 54 | 28 | 2 |
| Income taxes - deferred | -303 | N/A | N/A | N/A | N/A |
| Accounts receivable | 572 | -4 | -35 | -9 | N/A |
| Other Working Capital | 2,969 | 482 | -352 | -112 | 527 |
| Other Operating Activity | 13,620 | 3,916 | 4,647 | 2,506 | 382 |
| Operating Cash Flow | $-8,372 | $-4,732 | $-6,132 | $-3,639 | $-834 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,388 | -10 | -118 | -43 | N/A |
| Other Investing Activity | -263 | 0 | 271 | 0 | 0 |
| Investing Cash Flow | $-2,651 | $-10 | $153 | $-43 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,918 | 132 | 337 | 180 | 203 |
| Debt Issued | 1,954 | N/A | N/A | 250 | 250 |
| Debt Repayment | -15 | -25 | -21 | -21 | N/A |
| Common Stock Issued | N/A | 2,899 | 7,939 | 3,573 | 872 |
| Other Financing Activity | 12,927 | -136 | -409 | -353 | -30 |
| Financing Cash Flow | $17,784 | $2,869 | $7,847 | $3,630 | $1,295 |
| Exchange Rate Effect | -32 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 431 | 2,304 | 437 | 489 | 28 |
| End Cash Position | 7,159 | 431 | 2,304 | 437 | 489 |
| Net Cash Flow | $6,729 | $-1,873 | $1,868 | $-52 | $461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,372 | -4,732 | -6,132 | -3,639 | -834 |
| Capital Expenditure | -2,388 | -10 | -118 | -43 | N/A |
| Free Cash Flow | -10,760 | -4,742 | -6,250 | -3,682 | -834 |